Taxing only the profit component of share buybacks would remove distortions in capital allocation and allow companies to ...
As the Union Budget 2026 draws closer, India Inc is keeping a close watch amid mounting global uncertainty and rising ...
(Alliance News) - The UK unemployment rate was steady while regular earnings growth slowed, GSK agrees to buy biopharmaceutical firm RAPT Therapeutics for USD2.2 billion and Informa reports "strong ...
Market News Updates News Commentary - Advanced sensing, autonomy, and AI-driven systems are quickly becoming the backbone of modern defense and security, and that shift is opening up meaningful ...
By freezing out new foreign drones, the FCC has set off a race to localize production in a market long dominated by China.
Drilling of new wells in the 11th phase of the South Pars gas field will begin soon to increase production. The completion of ...
President of Azerbaijan Ilham Aliyev as he responded to questions from business representatives from various countries during ...
Electric bus market promises huge opportunity despite logistics and geopolitical challenges. Success hinges on supply chain ...
The National Electrical Manufacturers Association (NEMA) expanded its Make It American domestic content certification program ...
Greenland-linked tariff threats have injected fresh uncertainty into transatlantic trade, triggering a risk-off shift in ...
GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...
EQT Life Sciences Backs Exciva with €51 Million Financing to Address Unmet Needs in Alzheimer’s Care
EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results